MARKET

CERS

CERS

Cerus
NASDAQ
2.210
-0.010
-0.45%
After Hours: 2.210 0 0.00% 16:00 02/23 EST
OPEN
2.200
PREV CLOSE
2.220
HIGH
2.300
LOW
2.150
VOLUME
809.71K
TURNOVER
0
52 WEEK HIGH
3.080
52 WEEK LOW
1.205
MARKET CAP
400.45M
P/E (TTM)
-7.9468
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at CERS last week (0212-0216)?
Weekly Report · 6d ago
Cerus: [Amend]Statement of acquisition of beneficial ownership by individuals
Press release · 02/15 08:11
Weekly Report: what happened at CERS last week (0205-0209)?
Weekly Report · 02/12 11:35
GE HealthCare Technologies Posts Upbeat Earnings, Joins Toyota, Spotify And Other Big Stocks Moving Higher On Tuesday
Shares of GE HealthCare Technologies Inc. Surged 8.3% to $79.50 on Tuesday. The company reported better-than-expected quarterly financial results and issued guidance. The Dow Jones gained around 70 points in Tuesday’s session. Other big stocks recording gains include Palantir Technologies and Spotify Technology.
Benzinga · 02/06 15:20
Madrigal Pharmaceuticals, Cerus among healthcare movers
Healthcare On the Move Madrigal Pharmaceuticals, Cerus among healthcare movers. S&P 500 Health Care Sector +0.33% to 1664.9. Health Care Equipment & Services contributes 0.12% to index. Tenax Therapeutics, Tenax and Helius Medical Technologies among top gainers.
Seeking Alpha · 02/06 15:00
Weekly Report: what happened at CERS last week (0129-0202)?
Weekly Report · 02/05 11:46
Weekly Report: what happened at CERS last week (0122-0126)?
Weekly Report · 01/29 11:32
Cerus: [Amend]Statement of acquisition of beneficial ownership by individuals
Press release · 01/26 18:01
More
About CERS
Cerus Corporation is a biomedical products company. It is focused on developing and commercializing the INTERCEPT Blood System to enhance blood safety. The INTERCEPT Blood System, which is based on its technology for controlling biological replication, is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. Its INTERCEPT Blood System is intended for use with blood components and certain of their derivatives, such as platelets, plasma, red blood cells. Its product or product candidate under development include INTERCEPT Blood System-Platelets, INTERCEPT Blood System-Plasma, INTERCEPT Blood System-Red Blood Cells and INTERCEPT Blood System-Cryoprecipitation. The INTERCEPT Blood System is designed to target and inactivate blood-borne pathogens, such as viruses, bacteria and parasites, as well as potentially harmful white blood cells, while preserving the therapeutic properties of platelet, plasma, red blood cell and IFC transfusion products.

Webull offers Cerus Corp stock information, including NASDAQ: CERS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CERS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CERS stock methods without spending real money on the virtual paper trading platform.